eISSN 2508-3589
pISSN 2508-1926

Table. 3.

Table. 3.

Primary treatments in the three study groups

Group 1 (25)Group 2 (20)Group 3 (16)Total
Observation6 (24.0)0 (0.0)0 (0.0)6 (9.8)
Biopsy1 (4.0)3 (15.0)2 (12.5)6 (9.8)
LSU +/- Brachy8 (32.0)1 (5.0)0 (0.0)9 (14.8)
LSU + Cat+/- Brachy1 (4.0)1 (5.0)0 (0.0)2 (3.3)
LSU + TPPV +/- Brachy4 (16.0)10 (50.0)3 (18.8) + 1*17 (27.9)+ 1*
LSU + TPPV + Cat +/- Brachy2 (8.0)3 (15.0) + 2*8 (50.0)13 (21.3)+ 2*
Combined silicone oil injection0 (0.0)8 (40.0)10 (62.5)18 (29.5)
External radiation0 (0.0)1 (5.0)1 (6.3)2 (3.3)
Enucleation0 (0.0)0 (0.0)1 (6.3)1 (1.6)
Follow-up loss3 (12.0)1 (5.0)1 (6.3)5 (8.2)

Values are presented as number (%).

LSU = lamellar sclerouvectomy; Brachy = brachy therapy; Cat = cataract extraction; TPPV = total pars plana vitrectomy.

Patients with malignancy or inconclusive biopsy results.

Korean J Ret 2019;4:23-31 https://doi.org/10.21561/jor.2019.4.1.23
© 2019 Korean J Ret